Bros. Advisors Lp Baker Buys 1,888,800 Shares of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Neoleukin Therapeutics, Inc. (NASDAQ:NLTX – Get Free Report) Director Bros. Advisors Lp Baker purchased 166,942 shares of the stock in a transaction on Thursday, August 17th. The stock was acquired at an average cost of $0.69 per share, for a total transaction of $115,189.98. Following the completion of the acquisition, the director now owns 5,612,949 […]
Oppenheimer reissued their market perform rating on shares of ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) in a research report report published on Thursday, Benzinga reports. They currently have a $25.00 price target on the biopharmaceutical company’s stock. Other analysts have also recently issued research reports about the stock. JMP Securities upped their price objective on […]
ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) had its target price lowered by Canaccord Genuity Group from $39.00 to $38.00 in a research report released on Thursday morning, Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. Other equities research analysts also recently issued reports about the company. StockNews.com began coverage […]
ACADIA Pharmaceuticals (NASDAQ:ACAD) Given New $23.00 Price Target at Oppenheimer themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.